Limited operating history
The company has only a short track record, so demand, margins, and execution are unproven.
- Scope
- Company-wide
- Materiality
- high
VitaNova Life Sciences Corp is a Nevada-incorporated U.S. company that operates through two main lines of business: business consulting services and the marketing and supply of healthcare products. Its healthcare offering includes anti-aging and dietary supplement products, along with health consultation services, sold to customers in the United States and selected international markets.
30,1 %
−1,2 %
+13,7 %
6.14
5.87
| % | |
|---|---|
| Consulting services | 50% Management, accounting, and finance advisory services for domestic and international clients. |
| Healthcare products | 40% Anti-aging and dietary supplement products marketed and supplied through distributor and direct channels. |
| Health consultation services | 10% Personalized health advice and nutrition/wellness planning tied to supplement sales. |
The company serves domestic and international customers that need business consulting, accounting, and finance support,...
Businesses and other clients buying management, accounting, and finance advisory services.
Restaurants and retailers purchasing healthcare products through distribution channels.
End customers buying anti-aging and dietary supplement products directly.
Consumers seeking personalized health advice and wellness plans tied to supplement use.
The company sells to customers in the United States and international markets, with reported major customer locations...
The company is building a two-segment model that combines consulting services with healthcare product marketing and...
Broader product availability can increase customer reach and support the healthcare segment.
Partnerships with healthcare institutions can improve credibility and access to buyers.
International sales reduce reliance on a single customer market and broaden demand sources.
The business faces start-up-stage execution risk, limited operating history, and dependence on additional capital to...
The company has only a short track record, so demand, margins, and execution are unproven.
Growth and working capital needs may require external funding, which can dilute shareholders or limit operations.
The company states it does not maintain insurance, increasing downside from claims or litigation.
A meaningful share of revenue is tied to a few markets, especially Hong Kong, China, and the U.S.
Supplements and anti-aging products face many substitutes and require marketing spend and channel access.
: 29.4.2026